ClinVar Miner

Submissions for variant NM_004364.5(CEBPA):c.217T>G (p.Phe73Val)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV002295975 SCV002596364 uncertain significance Acute myeloid leukemia 2022-08-18 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with CEBPA-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces phenylalanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 73 of the CEBPA protein (p.Phe73Val).
Ambry Genetics RCV003097914 SCV003556877 uncertain significance Inborn genetic diseases 2021-07-06 criteria provided, single submitter clinical testing The c.217T>G (p.F73V) alteration is located in exon 1 (coding exon 1) of the CEBPA gene. This alteration results from a T to G substitution at nucleotide position 217, causing the phenylalanine (F) at amino acid position 73 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.